Colossal Biosciences was last valued at $25B (rumored). It comes from the Series Rumored of Jul 2026. The company is private, so there is no listed share price.
4 valuations. The latest, $25B rumored, was set by the Series Rumored in Jul 2026.
A private valuation is the price agreed in one transaction. The Colossal Biosciences valuation of $25B is a rumored figure from the Series Rumored dated 20 Jul 2026 .
The valuation holds until the next priced round or secondary sale. A private company founded in 2021 with roughly 170 people has no daily price and no order book between rounds.
Lead investors for each round are in the funding timeline.
The closest biotechnology peers are on the competitors page.
The routes section explains what is realistically available for a company at this stage.
No. Colossal Biosciences is a private company; its shares do not trade on a public exchange.
The last valuation is $25B (rumored, Jul 2026).
Perpetual markets for stocks, gold, indices and pre-IPO names — settled on-chain, no wallet-to-exchange transfers.
